Skip to main content

Table 1 Baseline characteristics according to the glycemic status

From: Prediabetes and all-cause mortality in young patients undergoing coronary artery angiography: a multicenter cohort study in China

Characteristic

Metabolic status

Overall

Normoglycemia

Prediabetes

Diabetes

P-value

n = 8868

n = 3410

n = 3240

n = 2218

 

Demographic characteristics

 Age(years)

44.0 ± 6.9

42.5 ± 7.2

44.8 ± 6.5

45.0 ± 6.6

 < 0.001

 Female

4112(46.4%)

1408(41.3%)

1585(48.9%)

1119(50.5%)

 < 0.001

Medical history and clinical condition

 Smoke

    

0.197

  None

4533(74.5)

1688(73.4)

1742(74.3)

1103(76.5)

 

  Current

1316(21.6)

517(22.5)

518(22.1)

281(19.5)

 

  Past

235(3.9)

94(4.1)

84(3.6)

57(4.0)

 

  AMI

1754(20.0)

665(19.6)

526(16.5)

563(25.6)

 < 0.001

  CHF

984(11.2)

311(9.2)

327(10.2)

346(15.7)

 < 0.001

  CKD

511(5.8)

135(4.0)

159(4.9)

217(9.8)

 < 0.001

  CAD

4777(54.4)

1685(49.7)

1579(49.4)

1513(68.7)

 < 0.001

  PCI

3608(40.7)

1230(36.1)

1189(36.7)

1189(53.6)

 < 0.001

  COPD

11(0.1)

5(0.1)

2(0.1)

4(0.2)

0.428

  HT

3195(36.4)

999(29.5)

1109(34.7)

1087(49.4)

 < 0.001

  AF

338(3.8)

98(2.9)

157(4.9)

83(3.8)

 < 0.001

  SBP (mmHg)

126.8 ± 18.7

125.6 ± 18.0

126.3 ± 18.5

129.5 ± 19.8

 < 0.001

Laboratory examination

 HbA1c (%)

6.2 ± 1.4

5.3 ± 0.3

6.0 ± 0.2

7.8 ± 1.8

 < 0.001

 Neutrophil(× 1012/L)

5.3 ± 2.9

5.1 ± 2.8

5.0 ± 2.7

5.8 ± 3.1

 < 0.001

 Lymphocyte(× 1012/L)

2.1 ± 0.7

2.0 ± 0.7

2.2 ± 0.7

2.2 ± 0.8

 < 0.001

 Albumin(g/L)

39.2 ± 4.3

39.6 ± 4.2

39.2 ± 4.2

38.7 ± 4.7

 < 0.001

 TG (mmol/L)

1.9 ± 1. 6

1.6 ± 1.3

1.8 ± 1.3

2.4 ± 2.1

 < 0.001

 TC (mmol/L)

4.8 ± 1.3

4.7 ± 1.3

4.9 ± 1.3

4.9 ± 1.4

 < 0.001

 HDL-C(mmol/L)

1.1 ± 0.3

1.1 ± 0.3

1.1 ± 0.3

1.0 ± 0.3

 < 0.001

 LDL-C(mmol/L)

3. 0 ± 1.1

2.9 ± 1.0

3.1 ± 1.1)

3.0 ± 1.1

 < 0.001

 eGFR(ml/min/1.73m2)

100.4(85.2, 108.8)

101.8(87.3, 109.7)

99.5(85.0, 107.4)

100.4(80.9, 109.4)

 < 0.001

 Uric acid(μmol/L)

382.6 ± 114.8

374.3 ± 110.3

385.4 ± 111.6

391.6 ± 124.8

 < 0.001

Medication during hospitalization

 ACEI

2985(36.0)

1056(34.0)

1062(34.7)

867(40.7)

 < 0.001

 ARB

1535(18.5)

468(15.1)

544(17.8)

523(24.6)

 < 0.001

 β-blockers

5617(67.7)

1996(64.3)

1986(64.9)

1635(76.8)

 < 0.001

 CCB

1986(23.9)

737(23.7)

681(22.3)

568(26.7)

0.001

 Statins

6082(73.3)

2164(69.7)

2167(70.8)

1751(82.2)

 < 0.001

 Aspirin

5534(66.7)

1975(63.6)

1907(62.3)

1652(77.6)

 < 0.001

 Diuretic

1198(14.4)

355(11.4)

480(15.7)

363(17.1)

 < 0.001

  1. AMI acute myocardial infarction, CHF congestive heart failure, CKD chronic kidney disease, CAD coronary artery disease, PCI percutaneous interventions, COPD chronic obstructive pulmonary disease, HT hypertension, AF atrial fibrillation, SBP Systolic blood pressure, HbA1c glycosylated hemoglobin, TG triglycerides, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker